The Global Prevalence of Daptomycin, Tigecycline, Quinupristin/Dalfopristin, and Linezolid-resistant Staphylococcus Aureus and Coagulase-negative Staphylococci Strains: a Systematic Review and Meta-analysis

Overview

Journal Antimicrob Resist Infect Control

Publisher Biomed Central

Specialty Infectious Diseases

Date 2020 Apr 24

PMID 32321574

Citations 59

Authors

Aref Shariati

Masoud Dadashi

Zahra Chegini

Alex van Belkum

Mehdi Mirzaii

Seyed Sajjad Khoramrooz

Davood Darban-Sarokhalil

Affiliations

Soon will be listed here.

Abstract

Objective: Methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant coagulase-negative Staphylococcus (MRCoNS) are among the main causes of nosocomial infections, which have caused major problems in recent years due to continuously increasing spread of various antibiotic resistance features. Apparently, vancomycin is still an effective antibiotic for treatment of infections caused by these bacteria but in recent years, additional resistance phenotypes have led to the accelerated introduction of newer agents such as linezolid, tigecycline, daptomycin, and quinupristin/dalfopristin (Q/D). Due to limited data availability on the global rate of resistance to these antibiotics, in the present study, the resistance rates of S. aureus, Methicillin-resistant S. aureus (MRSA), and CoNS to these antibiotics were collected.

Method: Several databases including web of science, EMBASE, and Medline (via PubMed), were searched (September 2018) to identify those studies that address MRSA, and CONS resistance to linezolid, tigecycline, daptomycin, and Q/D around the world.

Result: Most studies that reported resistant staphylococci were from the United States, Canada, and the European continent, while African and Asian countries reported the least resistance to these antibiotics. Our results showed that linezolid had the best inhibitory effect on S. aureus. Although resistances to this antibiotic have been reported from different countries, however, due to the high volume of the samples and the low number of resistance, in terms of statistical analyzes, the resistance to this antibiotic is zero. Moreover, linezolid, daptomycin and tigecycline effectively (99.9%) inhibit MRSA. Studies have shown that CoNS with 0.3% show the lowest resistance to linezolid and daptomycin, while analyzes introduced tigecycline with 1.6% resistance as the least effective antibiotic for these bacteria. Finally, MRSA and CoNS had a greater resistance to Q/D with 0.7 and 0.6%, respectively and due to its significant side effects and drug-drug interactions; it appears that its use is subject to limitations.

Conclusion: The present study shows that resistance to new agents is low in staphylococci and these antibiotics can still be used for treatment of staphylococcal infections in the world.

Citing Articles

Comprehensive safety and toxicity analysis of 2,2'-Bipyridine derivatives in combating MRSA biofilm formation and persistence.

Priyanka , Sharma M, Vaid B, Bharti R, Raut S, Jolly R Front Cell Infect Microbiol. 2025; 15:1493679.

PMID: 39925377 PMC: 11802822. DOI: 10.3389/fcimb.2025.1493679.

Antimicrobials in Orthopedic Infections: Overview of Clinical Perspective and Microbial Resistance.

Huzum B, Aprotosoaie A, Alexa O, Sirbu P, Puha B, Veliceasa B Medicina (Kaunas). 2025; 60(12.

PMID: 39768868 PMC: 11728363. DOI: 10.3390/medicina60121988.

The prevalence of multidrug resistance in Staphylococcus hominis isolated from clinical materials.

Szemraj M, Glajzner P, Olszowiec K, Sienkiewicz M Sci Rep. 2025; 15(1):414.

PMID: 39747570 PMC: 11696355. DOI: 10.1038/s41598-024-84500-2.

An Optimized Marinopyrrole A Derivative Targets 6-Phosphoglucosamine Synthetase to Inhibit Methicillin-Resistant .

Guo F, Xiao F, Song H, Li X, Xiao Y, Qin Y ACS Cent Sci. 2024; 10(11):2090-2098.

PMID: 39634224 PMC: 11613329. DOI: 10.1021/acscentsci.4c01167.

Repurposing TAK-285 as An Antibacterial Agent against Multidrug-Resistant Staphylococcus aureus by Targeting Cell Membrane.

Huang J, Xu Z, He P, Lin Z, Peng R, Yu Z Curr Microbiol. 2024; 82(1):8.

PMID: 39585416 DOI: 10.1007/s00284-024-04001-3.

References

Jones R, Ross J, Bell J, Utsuki U, Fumiaki I, Kobayashi I . Zyvox Annual Appraisal of Potency and Spectrum program: linezolid surveillance program results for 2008. Diagn Microbiol Infect Dis. 2009; 65(4):404-13. DOI: 10.1016/j.diagmicrobio.2009.10.001. View

Peterson L . A review of tigecycline--the first glycylcycline. Int J Antimicrob Agents. 2009; 32 Suppl 4:S215-22. DOI: 10.1016/S0924-8579(09)70005-6. View

Abdel-Hamid M, Phillips O . LC-MS/MS determination of Synercid injections. J Pharm Biomed Anal. 2003; 32(6):1167-74. DOI: 10.1016/s0731-7085(03)00231-0. View

Picazo J, Betriu C, Rodriguez-Avial I, Culebras E, Lopez F, Gomez M . [Comparative activity of daptomycin against clinical isolates of methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci]. Enferm Infecc Microbiol Clin. 2009; 28(1):13-6. DOI: 10.1016/j.eimc.2008.09.012. View

Abbasian S, Farahani N, Mir Z, Alinejad F, Haeili M, Dahmardehei M . Genotypic characterization of isolated from a burn centre by using and SCC typing methods. New Microbes New Infect. 2018; 26:15-19. PMC: 6141672. DOI: 10.1016/j.nmni.2018.08.001. View

DerSimonian R, Laird N . Meta-analysis in clinical trials. Control Clin Trials. 1986; 7(3):177-88. DOI: 10.1016/0197-2456(86)90046-2. View

Silverman J, Oliver N, Andrew T, Li T . Resistance studies with daptomycin. Antimicrob Agents Chemother. 2001; 45(6):1799-802. PMC: 90548. DOI: 10.1128/AAC.45.6.1799-1802.2001. View

Jevitt L, Smith A, Williams P, Raney P, McGowan Jr J, Tenover F . In vitro activities of Daptomycin, Linezolid, and Quinupristin-Dalfopristin against a challenge panel of Staphylococci and Enterococci, including vancomycin-intermediate staphylococcus aureus and vancomycin-resistant Enterococcus faecium. Microb Drug Resist. 2004; 9(4):389-93. DOI: 10.1089/107662903322762833. View

Cui L, Wang Y, Li Y, He T, Schwarz S, Ding Y . Cfr-mediated linezolid-resistance among methicillin-resistant coagulase-negative staphylococci from infections of humans. PLoS One. 2013; 8(2):e57096. PMC: 3577776. DOI: 10.1371/journal.pone.0057096. View

10.

Mantel N, Haenszel W . Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959; 22(4):719-48. View

11.

Francia M, Clewell D . Transfer origins in the conjugative Enterococcus faecalis plasmids pAD1 and pAM373: identification of the pAD1 nic site, a specific relaxase and a possible TraG-like protein. Mol Microbiol. 2002; 45(2):375-95. DOI: 10.1046/j.1365-2958.2002.03007.x. View

12.

Sader H, Fritsche T, Streit J, Jones R . Daptomycin in vitro activity tested against Gram-positive strains collected from European and Latin American medical centers in 2003. J Chemother. 2005; 17(5):477-83. DOI: 10.1179/joc.2005.17.5.477. View

13.

Higgins J, Thompson S . Quantifying heterogeneity in a meta-analysis. Stat Med. 2002; 21(11):1539-58. DOI: 10.1002/sim.1186. View

14.

Zhanel G, Decorby M, Nichol K, Wierzbowski A, Baudry P, Karlowsky J . Antimicrobial susceptibility of 3931 organisms isolated from intensive care units in Canada: Canadian National Intensive Care Unit Study, 2005/2006. Diagn Microbiol Infect Dis. 2008; 62(1):67-80. DOI: 10.1016/j.diagmicrobio.2008.04.012. View

15.

Darban-Sarokhalil D, Khoramrooz S, Marashifard M, Malek Hosseini S, Parhizgari N, Yazdanpanah M . Molecular characterization of Staphylococcus aureus isolates from southwest of Iran using spa and SCCmec typing methods. Microb Pathog. 2016; 98:88-92. DOI: 10.1016/j.micpath.2016.07.003. View

16.

Rosenthal M, Mediavilla J, Chen L, Sonnenfeld J, Pierce L, Shannon A . Molecular epidemiology of Staphylococcus aureus in post-earthquake northern Haiti. Int J Infect Dis. 2014; 29:146-51. DOI: 10.1016/j.ijid.2014.08.007. View

17.

Chen Y, Liu C, Ko W, Liao C, Lu P, Huang C . Trends in the susceptibility of methicillin-resistant Staphylococcus aureus to nine antimicrobial agents, including ceftobiprole, nemonoxacin, and tyrothricin: results from the Tigecycline In Vitro Surveillance in Taiwan (TIST) study, 2006-2010. Eur J Clin Microbiol Infect Dis. 2013; 33(2):233-9. DOI: 10.1007/s10096-013-1949-y. View

18.

Ballow C, Jones R, Biedenbach D . A multicenter evaluation of linezolid antimicrobial activity in North America. Diagn Microbiol Infect Dis. 2002; 43(1):75-83. DOI: 10.1016/s0732-8893(01)00334-0. View

19.

Sader H, Watters A, Fritsche T, Jones R . Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centers (2005). BMC Infect Dis. 2007; 7:29. PMC: 1865382. DOI: 10.1186/1471-2334-7-29. View

20.

Brzychczy-Wloch M, Borszewska-Kornacka M, Gulczynska E, Wojkowska-Mach J, Sulik M, Grzebyk M . Prevalence of antibiotic resistance in multi-drug resistant coagulase-negative staphylococci isolated from invasive infection in very low birth weight neonates in two Polish NICUs. Ann Clin Microbiol Antimicrob. 2013; 12:41. PMC: 3898809. DOI: 10.1186/1476-0711-12-41. View